Silversmith Capital Partners Announces New Industry Advisory Board Member

Go back to Silversmith Capital Partners Announces New Industry Advisory Board Member

athenahealth (ATHN) PT Lowered to $123 at UBS

May 1, 2017 10:08 AM EDT

UBS lowered its price target on athenahealth (NASDAQ: ATHN) to $123.00 (from $140.00) while maintaining a Buy rating.

UBS reduced revenue estimates, with FY17 revenues down from $1.29Bn to $1.22Bn and FY18 revenues down from $1.50Bn to $1.41Bn. FY17 EPS was also reduced from $2.44 to $2.12 and FY18 EPS from $3.05 to $2.56.

... More